Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Kathleen Michelle Andersen Jonathan Toh Leong Cheah Lyn M March Susan J Bartlett Dorcas E Beaton Clifton O Bingham Peter R Brooks Robin Christensen Philip Gerard Conaghan Maria Antonietta D'Agostino Maarten P T de Wit Amylou C Dueck Susan M Goodman Shawna Grosskleg Catherine L Hill Martin Howell Sarah Louise Mackie Bethan Richards Beverley J Shea Jasvinder A Singh Vibeke Strand Peter Tugwell George A Wells Lee S Simon

Published in: The Journal of rheumatology (2019)

Current approaches have failed to include data from the patient's perspective. A better understanding of how individuals with rheumatic diseases view potential benefits and harms of therapies is essential.

Keyphrases

case report
randomized controlled trial
big data
electronic health record
systematic review
machine learning
risk assessment
human health
climate change